01 3Aplenzin
02 3Aplenzin?
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 98
2019 Revenue in Millions : 83
Growth (%) : 18
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 109
2020 Revenue in Millions : 98
Growth (%) : 11
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 83
2018 Revenue in Millions : 54
Growth (%) : 54
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 42
2015 Revenue in Millions : 40
Growth (%) : 5
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 31
2016 Revenue in Millions : 42
Growth (%) : -26
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 54
2017 Revenue in Millions : 31
Growth (%) : 74%
LOOKING FOR A SUPPLIER?